PPARγ activation enhances cell surface ENaCα via up-regulation of SGK1 in human collecting duct cells

FASEB Journal

Volumn 17, Issue 13, 2003, Pages 1-17

  Hong, Guizhu ^a   Lockhart, Andrew ^a   Davis, Bill ^a   Rahmoune, Hassan ^a   Baker, Sharon ^a   Ye, Liang ^a   Thompson, Paul ^a   Shou, Yaping ^b   O’Shaughnessy, Kevin ^a   Ronco, Pierre ^c   Brown, John ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c INSERM   (France)

Author keywords

Nuclear receptor; PPAR agonists; Sodium retention

Indexed keywords

ALDOSTERONE; AQUAPORIN 2; EPITHELIAL SODIUM CHANNEL; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RETINOID X RECEPTOR GAMMA; ROSIGLITAZONE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM; WATER;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUID RETENTION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY COLLECTING TUBULE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM ABSORPTION; SODIUM RETENTION; UPREGULATION;

EID: 85076402204     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.03-0181fje     Document Type: Article

References (39)

1. Kersten, S., Desvergne, B., and Wahli, W. (2000) Roles of PPARs in health and disease. Nature 405, 421–424
2. Willson, T. M., Brown, P. J., Sternbach, D. D., and Henke, B. R. (2000) The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43, 527–550
3. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., and Evans, R. M. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771–774
4. Palmer, C. N., Hsu, M. H., Griffin, H. J., and Johnson, E. F. (1995) Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270, 16114–16121
5. Murphy, G. J., and Holder, J. C. (2000) PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. Sci. 21, 469–474
6. Kassam, A., Hunter, J., Rachubinski, R. A., and Capone, J. P. (1998) Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma. Mol. Cell. Endocrinol. 141, 153–162
7. Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., and Kliewer, S. A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270, 12953–12956
8. Mukherjee, R., Jow, L., Croston, G. E., and Paterniti, J. R., Jr. (1997) Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272, 8071–8076
9. Yang, T., Michele, D. E., Park, J., Smart, A. M., Lin, Z., Brosius, F. C., III, Schnermann, J. B., and Briggs, J. P. (1999) Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am. J. Physiol. 277, F966–F973
10. Guan, Y., Zhang, Y., Davis, L., and Breyer, M. D. (1997) Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am. J. Physiol. 273, F1013–F1022
11. Firsov, D., Gautschi, I., Merillat, A. M., Rossier, B. C., and Schild, L. (1998) The heterotetrameric architecture of the epithelial sodium channel (ENaC). EMBO J. 17, 344–352
12. Kosari, F., Sheng, S., Li, J., Mak, D. O., Foskett, J. K., and Kleyman, T. R. (1998) Subunit stoichiometry of the epithelial sodium channel. J. Biol. Chem. 273, 13469–13474
13. Masilamani, S., Kim, G. H., Mitchell, C., Wade, J. B., and Knepper, M. A. (1999) Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J. Clin. Invest. 104, R19–R23
14. Verrey, F. (1999) Early aldosterone action: toward filling the gap between transcription and transport. Am. J. Physiol. 277, F319–F327
15. Webster, M. K., Goya, L., Ge, Y., Maiyar, A. C., and Firestone, G. L. (1993) Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol. Cell. Biol. 13, 2031–2040
16. Chen, S. Y., Bhargava, A., Mastroberardino, L., Meijer, O. C., Wang, J., Buse, P., Firestone, G. L., Verrey, F., and Pearce, D. (1999) Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc. Natl. Acad. Sci. USA 96, 2514–2519
17. Naray-Fejes-Toth, A., Canessa, C., Cleaveland, E. S., Aldrich, G., and Fejes-Toth, G. (1999) sgk is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial na+ channels. J. Biol. Chem. 274, 16973–16978
18. Loffing, J., Zecevic, M., Feraille, E., Kaissling, B., Asher, C., Rossier, B. C., Firestone, G. L., Pearce, D., and Verrey, F. (2001) Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting system: possible role of SGK. Am. J. Physiol. Renal Fluid & Electrolyte Physiol. 280, F675–F682
19. Park, J., Leong, M. L., Buse, P., Maiyar, A. C., Firestone, G. L., and Hemmings, B. A. (1999) Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J. 18, 3024–3033
20. Wang, J., Barbry, P., Maiyar, A. C., Rozansky, D. J., Bhargava, A., Leong, M., Firestone, G. L., and Pearce, D. (2001) SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. American Journal of Physiology - Renal Fluid & Electrolyte Physiology 280, F303–F313
21. Faletti, C. J., Perrotti, N., Taylor, S. I., and Blazer-Yost, B. L. (2002) sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport. Am. J. Physiol. Cell Physiol. 282, C494–C500
22. Debonneville, C., Flores, S. Y., Kamynina, E., Plant, P. J., Tauxe, C., Thomas, M. A., Munster, C., Chraibi, A., Pratt, J. H., Horisberger, J. D., et al. (2001) Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na(+) channel cell surface expression. EMBO J. 20, 7052–7059
23. Prie, D., Friedlander, G., Coureau, C., Vandewalle, A., Cassingena, R., and Ronco, P. M. (1995) Role of adenosine on glucagon-induced cAMP in a human cortical collecting duct cell line. Kidney Int. 47, 1310–1318
24. Henke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins, J. L., Harrington, W. W., Jr., Hashim, M. A., Hull-Ryde, E. A., Kaldor, I., et al. (1998) N-(2Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J. Med. Chem. 41, 5020–5036
25. Wang, T., and Brown, M. J. (1999) mRNA quantification by real time TaqMan polymerase chain reaction: validation and comparison with RNase protection. Anal. Biochem. 269, 198–201
26. Hanwell, D., Ishikawa, T., Saleki, R., and Rotin, D. (2002) Trafficking and cell surface stability of the epithelial Na+ channel expressed in epithelial Madin-Darby canine kidney cells. J. Biol. Chem. 277, 9772–9779
27. Guan, Y., and Breyer, M. D. (2001) Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int. 60, 14–30
28. Pearce, D. (2001) The role of SGK1 in hormone-regulated sodium transport. Trends Endocrinol. Metab. 12, 341–347
29. Takeda, K., Ichiki, T., Tokunou, T., Iino, N., and Takeshita, A. (2001) 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J. Biol. Chem. 276, 48950–48955
30. Rieusset, J., Roques, M., Bouzakri, K., Chevillotte, E., and Vidal, H. (2001) Regulation of p85alpha phosphatidylinositol-3-kinase expression by peroxisome proliferator-activated receptors (PPARs) in human muscle cells. FEBS Lett. 502, 98–102
31. Blazer-Yost, B. L., Paunescu, T. G., Helman, S. I., Lee, K. D., and Vlahos, C. J. (1999) Phosphoinositide 3-kinase is required for aldosterone-regulated sodium reabsorption. Am. J. Physiol. 277, C531–C536
32. Downward, J. (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10, 262–267
33. Leesnitzer, L. M., Parks, D. J., Bledsoe, R. K., Cobb, J. E., Collins, J. L., Consler, T. G., Davis, R. G., Hull-Ryde, E. A., Lenhard, J. M., Patel, L., et al. (2002) Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41, 6640–6650
34. Juge-Aubry, C., Pernin, A., Favez, T., Burger, A. G., Wahli, W., Meier, C. A., and Desvergne, B. (1997) DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem. 272, 25252–25259
35. Alvarez, D.L.R., Zhang, P., Naray-Fejes-Toth, A., Fejes-Toth, G., and Canessa, C. M. (1999) The serum and glucocorticoid kinase sgk increases the abundance of epithelial sodium channels in the plasma membrane of Xenopus oocytes. J. Biol. Chem. 274, 37834–37839
36. May, A., Puoti, A., Gaeggeler, H. P., Horisberger, J. D., and Rossier, B. C. (1997) Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel alpha subunit in A6 renal cells. J. Am. Soc. Nephrol. 8, 1813–1822
37. Yoshimoto, T., Naruse, M., Nishikawa, M., Naruse, K., Tanabe, A., Seki, T., Imaki, T., Demura, R., Aikawa, E., and Demura, H. (1997) Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats. Am. J. Physiol. 272, E989–E996
38. Gorson, D. M. (1999) Significant weight gain with rezulin therapy. Arch. Intern. Med. 159, 99
39. Jackson, K. E. (1996). Diuretics. In The Pharmacological Basis of Therapeutics (Hardman, J. G. and Limbird E. L., eds.) McGraw-Hill, New York, NY; pp. 685–713